Support Urged for ‘Justice for ALS Veterans Act’ Sitting in US Congress
The ALS Association and Paralyzed Veterans of America (PVA) are pressing the Congress to pass legislation boosting the…
Articles by Mary Chapman
ALS Success Story Delivers Man’s ‘Most Special Day’
The Lifestyle Healing Institute (LHI), which uses a complementary and alternative medicine approach to care, is touting the success…
Nearly 2,000 ALS Patients in US Being Treated With Radicava ORS
Nearly 2,000 amyotrophic lateral sclerosis (ALS) patients in the United States have been treated with Radicava ORS (edaravone) since the oral suspension…
FDA and NIH Open Initiative to Spur ALS Research, Potential Treatments
The U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) have forged a partnership that seeks…
Verge Genomics Named ‘Fierce 15’ Biotech for Novel Work in ALS
The treatment development company Verge Genomics — known for its all-in-human artificial intelligence platform — has been named among…
Kulicke & Soffa Donation Expands Access to Investigational Therapies
Kulicke & Soffa Industries has announced a multi-year donation that ultimately will increase amyotrophic lateral sclerosis (ALS) patients’ access…
Cytokinetics Adds Decade of Trial Findings to PRO-ACT Database
The Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) database, the largest collection of de-identified records on amyotrophic lateral sclerosis (ALS)…
MDA & ALS Care Center’s Alan Pestronk Wins MDA’s Tribute Award
As part of its Tribute Awards, the Muscular Dystrophy Association (MDA) will honor Alan Pestronk, MD, co-director of the…
PrimeC Trial Findings to Aid in Identifying Facial Biomarkers of ALS
NeuroSense Therapeutics and NeuraLight are collaborating to identify digital biomarkers, particularly those drawn from facial videos, that would…
NIH $2.3M Grant to Test App to Diagnose, Monitor ALS at Home
The National Institutes of Health (NIH) has awarded $2.3 million to advance into testing an app that could improve how …